-+ 0.00%
-+ 0.00%
-+ 0.00%

MUSTANG BIO GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA FOR MB-101 (IL13RA2-TARGETED CAR T-CELLS) TO TREAT ASTROCYTOMAS AND GLIOBLASTOMA

Reuters·07/07/2025 12:30:55

Please log in to view news